The first factor that impacts the patient’s health and hypertension treatment pattern is his gender. It has been statistically proven that men have higher rates of hypertension occurrence. Also, we should consider the fact that CF is sixty years old as in younger males the hypertension occurrence rates are not that high. The ethnic variances in retort between beta-blockers and ACE obstructers in hypertension are conceivably the typically predictable instances of racial differences in retort to cardiovascular medications (Anthony, Valinsky, Inbar, Gabriel, & Varda, 2012). Numerous studies found that results were better or not diverse with ACE obstructers as opposed to beta-blocker or calcium canal blocker treatment in African-Americans. Moreover, equated to Caucasians and further ethnic clusters, African-Americans are much more prospective to have blood pressure outside the regulated norms. Another point is CF’s BMI, which is not within the normal range (Anthony et al., 2012). It is safe to say that about 30% of patients with high blood pressure are slightly obese or explicitly overweight. Even abstemiously overweight grown persons have double the hazard of hypertension than individuals with ordinary weightiness.
The thorough analysis of the affecting factors shows that a systematized organization of recordkeeping, recollection, and consistent assessment related to a dynamic stepped care method utilizing antihypertensive medication treatment seems to be the probable way to advance the regulation of blood pressure that is not in the normal range (James et al., 2014). The nurse should monitor the response to the suppositories to regulate CF’s blood pressure. The response to medication treatment is reliant on both the person as well as the synergistic outcomes produced by the medications. As a consequence of secondary effects, medication interactions, and the patient’s incentive for exploiting an antihypertensive suppository, it is imperative to use the minimum amount and lowermost dosage of medicines (James et al., 2014).
As CF is a patient with diabetes, the nurse should utilize Corgard with carefulness for the reason that they can extend and cover the hypoglycemic impact of insulin (the same goes for Visken). The original dosage is 40 mg once every day, whether it is utilized discretely or along with diuretic treatment (James et al., 2014). The dose may be progressively augmented in 40 to 80 mg raises until the optimal blood pressure decrease is attained. The typical maintenance dosage of 40 to 80 mg should be directed once day-to-day. Another reason why he may necessitate reduced dosages is that of the inclination to hypotension and bradycardia. African-American patients tend to be not so reactive to beta-blockers on the whole and may need an improved prescription or use of another medication (mono treatment with an ACE inhibitor).
Consistent physical actions can assist in lowering CF’s blood pressure, manage tension, decrease his risk of more than a few health complications, and preserve his weight closely controlled (Anthony et al., 2012). Losing weight can help CF control his high blood pressure and diminish his risk of associated health complications. Losing even four to ten pounds can moderate his blood pressure. It is important to decrease stress and incorporate vigorous coping methods, such as relaxation, contemplation, or deep respiration (Anthony et al., 2012). Having adequate sleep can assist in this situation, too. Home-based blood pressure maintenance can help CF monitor his blood pressure, display if medication is efficient, and even warn him of the likely difficulties (Anthony et al., 2012).
References
Anthony, H., Valinsky, L., Inbar, Z., Gabriel, C., & Varda, S. (2012). Perceptions of Hypertension Treatment Among Patients with and without Diabetes. BMC Fam Pract BMC Family Practice, 13(1), 13-24. Web.
James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J.,… Ortiz, E. (2014). 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults. Jama, 311(5), 507. Web.